« Previous
Next »
Journal of Hepatology
Volume 49, Issue 3
, Pages 339-345
, September 2008
Evaluation of complement factor 5 variants as genetic risk factors for the development of advanced fibrosis in chronic hepatitis C infection
To access this article, please choose from the options below
☆ Dr. Landt is employed by TIB MOLBIOL, Berlin, Germany. The authors declare that they do not have anything to disclose regarding funding from industries or conflict of interest with respect to this manuscript.
PII: S0168-8278(08)00371-1
doi: 10.1016/j.jhep.2008.05.021
© 2008 European Association for the Study of the Liver. Published by Elsevier Inc. All rights reserved.
« Previous
Next »
Journal of Hepatology
Volume 49, Issue 3
, Pages 339-345
, September 2008
